Cybin (TSE:CYBN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cybin Inc., a leader in neuropsychiatry treatments, announced that their Chief Medical Officer will participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. The company specializes in innovative therapies for mental health conditions, including a psilocin program for depression and a DMT program for anxiety that are advancing through clinical trials.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.